본문으로 건너뛰기
← 뒤로

Malignant Craniofacial Perivascular Epithelioid Cell Tumor: A Review of Literature With a Rare Presentation.

Head & neck 2026 Vol.48(5) p. E46-E53 Tuberous Sclerosis Complex Research
TL;DR An overview of current biomarker testing in the context of current treatment options for cancer of the upper gastrointestinal tract is provided.
OpenAlex 토픽 · Tuberous Sclerosis Complex Research Tumors and Oncological Cases Vascular Tumors and Angiosarcomas

Paris J, Abdullah A, Ang T, Shepard S, Selva D, Psaltis AJ

📝 환자 설명용 한 줄

An overview of current biomarker testing in the context of current treatment options for cancer of the upper gastrointestinal tract is provided.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Jai Paris, Almater Abdullah, et al. (2026). Malignant Craniofacial Perivascular Epithelioid Cell Tumor: A Review of Literature With a Rare Presentation.. Head & neck, 48(5), E46-E53. https://doi.org/10.1002/hed.70126
MLA Jai Paris, et al.. "Malignant Craniofacial Perivascular Epithelioid Cell Tumor: A Review of Literature With a Rare Presentation.." Head & neck, vol. 48, no. 5, 2026, pp. E46-E53.
PMID 41367329
DOI 10.1002/hed.70126

Abstract

[BACKGROUND] Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms with smooth muscle and melanocytic differentiation, typically occurring in genitourinary or abdominopelvic sites. While multiple anatomic sites have been reported, craniofacial involvement is exceptionally rare.

[METHODS] We report the first documented case of a probable high-grade malignant PEComa of the sinonasal tract with anterior skull base and orbital extension. The patient was a 42-year-old woman with a germline RB1 mutation, prior radiotherapy for bilateral retinoblastoma as an infant, and a history of left-sided sinonasal leiomyosarcoma treated with surgical resection and anthracycline chemotherapy. She represented six years later with new contralateral epistaxis and a friable right-sided nasal mass. Upon endoscopy and imaging, a locally aggressive lesion was confirmed.

[RESULTS] Histopathology showed a highly proliferative tumor with immunohistochemistry positive for HMB45, melan-A, SMA, caldesmon, and TFE3, with absent desmin and MITF. The lesion was most in keeping with a malignant PEComa. The tumor was resected via a combined transcranial, transcaruncular, and endoscopic endonasal approach, achieving clear margins. This case shows unusually rapid progression, likely influenced by prior radiation and germline RB1 gene mutation. Our literature review identified 41 previously reported primary craniofacial PEComas, consisting of 51% sinonasal, 37% orbital, and 10% skull base. Nearly all cases were benign and treated with surgical resection.

[CONCLUSIONS] This report highlights a rare, malignant craniofacial PEComa with extensive invasion into the orbit and skull base, expanding the known clinical and molecular spectrum of these tumors.

MeSH Terms

Humans; Female; Adult; Perivascular Epithelioid Cell Neoplasms; Paranasal Sinus Neoplasms; Immunohistochemistry

같은 제1저자의 인용 많은 논문 (1)